TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain by Natalia Reglińska-Matveyev, Helena M. Andersson, Suely M. Rezende,

Slides:



Advertisements
Similar presentations
Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial- induced signalling and cytokine secretion by.
Advertisements

Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene by Christof Dame, Karin M. Kirschner, Katharina V. Bartz, Thomas.
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Tumor cell–associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell–dependent.
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B- cell lymphomas by Lingchen Fu, Yen-Chiu Lin-Lee,
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1 by Ilka Ott, Martin.
Activation of factor XI by products of prothrombin activation
Modulation of hemostatic mechanisms in bacterial infectious diseases
Thrombin and fibrinogen γ′ impact clot structure by marked effects on intrafibrillar structure and protofibril packing by Marco M. Domingues, Fraser L.
by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and
Polyphosphates rock! A role in thrombosis?
Protein S Gla-domain mutations causing impaired Ca2+-induced phospholipid binding and severe functional protein S deficiency by Suely M. Rezende, David.
High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors by Glaivy Batsuli, Wei Deng, John.
Vessel wall BAMBI contributes to hemostasis and thrombus stability
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C–mediated proteolysis by.
Thanks for the complement (inhibitor)‏
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
by Xiuli An, Emilie Gauthier, Xihui Zhang, Xinhua Guo, David J
Factor V: a combination of Dr Jekyll and Mr Hyde
Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,
The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII by Kagehiro Amano,
Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface by Hironao Wakabayashi, Fatbardha Varfaj,
Important port for SHIP-1 at Dok-3
Genetic sequence analysis of inherited bleeding diseases
von Willebrand factor is a cofactor in complement regulation
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk by Alisa S. Wolberg, Dougald.
by Robert F. Kelley, Canio J. Refino, Mark P
Zinc fingers poke zebrafish, cause thrombosis!
by Peter L. Turecek, Hans Peter Schwarz, and Bernd R. Binder
Suppression, surprise: galectin-10 and Treg cells
Anti–factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome by Mihály Józsi, Stefanie Strobel, Hans-Martin.
The γ-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding.
Coagulation and innate immune responses: can we view them separately?
The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies by.
Taking a leaf from the book of oral tolerance
by Wu-Guo Deng, Ying Zhu, and Kenneth K. Wu
New checkpoint of the coagulant phenotype
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
by Cornelis van 't Veer, Neal J. Golden, and Kenneth G. Mann
by Matthew F. Whelihan, Vicentios Zachary, Thomas Orfeo, and Kenneth G
by Parisa Asvadi, Zohra Ahmadi, and Beng H. Chong
Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of.
Apoptotic Vascular Endothelial Cells Become Procoagulant
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Blocking VWF platelet binding to treat TTP
by Ronda K. Baker, Ebba U. Kurz, David W. Pyatt, Richard D
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity by Gary E. Gilbert, Valerie A. Novakovic,
A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex by Rinku Majumder, Mary Ann.
Mechanism of factor VIIa–dependent coagulation in hemophilia blood
Figure 2 Initiation, amplification and propagation of coagulation
Figure 1 The coagulation system
Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition.
Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration by Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque,
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling by Jeff S. Isenberg, Martin J.
TNF-α–stimulated adhesion of HL60 cells to HCMEC is inhibited by neuraminidase but not by NaClO3 . TNF-α–stimulated adhesion of HL60 cells to HCMEC is.
by Changjie Zhang, Anju Kelkar, and Sriram Neelamegham
Naturally Occurring Inhibitors
Rapamycin inhibits TCR/CD3 engagement-dependent HIF-1α protein expression. Rapamycin inhibits TCR/CD3 engagement-dependent HIF-1α protein expression. Human.
Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency by Michelle M. Castillo, Qiuhui.
Secretion is ablated in the absence of SNAP23.
Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera by Richard B. Pouw, Mieke C. Brouwer,
Actin assembly in response to thrombin.
Activation of PKR by the PBM decoy peptide.
Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies by Nadine Müller-Calleja, Svenja.
by Wendy Lim, Sara K. Vesely, and James N. George
Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: mode of its action by Shiva Keshava, Jagan Sundaram,
Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state by Jeremy P. Wood, Lisa M.
A binding relationship with thrombin
Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S by José A. Fernández, Xiao Xu, Ranjeet K.
Presentation transcript:

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain by Natalia Reglińska-Matveyev, Helena M. Andersson, Suely M. Rezende, Björn Dahlbäck, James T. B. Crawley, David A. Lane, and Josefin Ahnström Blood Volume 123(25): June 19, 2014 ©2014 by American Society of Hematology

Protein S enhancement of the TFPI-mediated inhibition of thrombin generation in protein S– depleted plasma. Natalia Reglińska-Matveyev et al. Blood 2014;123: ©2014 by American Society of Hematology

Enhancement of the TFPI-mediated inhibition of thrombin generation by WT protein S and protein S/Gas6 chimeras I to III. Thrombin generation was measured in protein S–depleted plasma supplemented with 50 μM phospholipids and 1 pM TF, in the presence or abse... Natalia Reglińska-Matveyev et al. Blood 2014;123: ©2014 by American Society of Hematology

Enhancement of TFPI in the inhibition of FXa by WT protein S and protein S/Gas6 chimeras I to III. FXa activity (0.5 nM) was followed in real time through cleavage of S-2765 (200 µM) at 405 mm in the presence of 25 μM phospholipids, the presence or absence... Natalia Reglińska-Matveyev et al. Blood 2014;123: ©2014 by American Society of Hematology

Enhancement of TFPI inhibition of FXa by protein S–, C4BP-, and C4BP-bound protein S. FXa activity (0.5 nM) was followed in real time through cleavage of S-2765 (200 µM) at 405 mm in the presence of 25 μM phospholipids, the presence or absence of TFPI (2 nM... Natalia Reglińska-Matveyev et al. Blood 2014;123: ©2014 by American Society of Hematology

Binding of WT protein S and protein S/Gas6 chimeras I to III to TFPI studied with SPR. A CM5 chip was coupled with TFPI immobilized to 2500 response units. Natalia Reglińska-Matveyev et al. Blood 2014;123: ©2014 by American Society of Hematology

Proposed mechanism of the protein S/TFPI/FXa complex assembly on a phospholipid surface. Natalia Reglińska-Matveyev et al. Blood 2014;123: ©2014 by American Society of Hematology